Tag: hepatitis c
Top 5 Infectious Disease Stories: Week of February 25
This week, why measles and vibrio vulnificus infections are seeing outbreaks and increases in incidence rates; a medical association recommends fecal microbiota-based therapies...
Self-Reported and Objective Compliance for HCV Treatment Reflect Different Cure Rates
The HERO (Hepatitis C Real Options) study found that self-reported compliance with direct-acting antiviral (DAA) therapy for HCV treatment in persons who inject...
Top 5 Infectious Disease Stories: Week of February 17
This week, in efforts to navigate malaria with treatments, prevention, and the impact of climate change, the FDA is not requesting further trials...
Global Access to Hepatitis C Treatments
A study published in The Lancet discusses access to reimbursement for direct-acting antivirals (DAAs) is globally uneven, with low and middle-income countries (LMICs)...
Achieving SVR Reduces Risk of Cardiovascular Events in Patients with HCV
This article originally appeared on our sister site, HCPLive. Hepatitis C virus (HCV) eradication with direct-acting antiviral (DAA) therapy may decrease the risk...
Overestimation of Hepatitis C Prevalence Hinders Cost-Effectiveness of Universal Screening
Aiden McCormickCredit: Irish ExaminerThis article originally appeared on our sister site, HCPLive. Findings from a pair of studies examining the community prevalence of...